Microsoft Word - ELCID_Telemax Capital Increase No. FER 600195 March 23, 2018 Subject : Notification of the capital increase and investment plan of its subsidiary Attention : President, The
% The Company and its subsidiaries had other income of Baht 741.35 million, a rise by Baht 375.49 million or 102.63% from the same period of last year. Most of the increase came from the interest income
growth was driven primarily by an increase in revenues from sales of pet skincare shampoo products, pet food products and livestock animal products, and revenues from sales of wellness & anti-ageing
%). This promising growth was due to more subspecialties as well as capacity expansion. OPD increased by 3 units and IPD increased by 17 units yoy. Number of OPD patients remained on the rise while revenue
together with a rise in revenues from sales of wellness and anti-aging Business Unit at Baht 128.58 million or increase of Baht 34.12 million or 26.54% in 2019 largely from sales of probiotic products such
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of
& vaccination) was on par with the previous year. This trend also incurred to IPD income with IPD visit number barely changed yoy. while revenue per visit has increased by 10% yoy. The increase of revenue per
% growth of revenue from sales of house and condominium units and 71% increase in revenue from rental and services attributed to the rise of total revenue. 2Q19 Net profit at THB 192m, or 56% decline YoY
8,875m, increased by 128% YoY. Major drivers of such growth were 298% increase in revenue from sales of house and condominium together with 38% increase in revenue from rental and services which mainly